mFluiDx (Seed)
Funding Details
- Date Award
- September 30, 2023
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Premoney Valuation
- $8,500,000
- Valuation
- $10,000,000
- Funding Amount:
- $1,500,000
Company Info
- Founding Year
- 2016
- Traction
- mFluiDx has successfully developed and launched several diagnostic tests, gaining traction in the market. They have secured partnerships with healthcare providers and organizations to deploy their tests in various settings.
- Organizations Involved
- SOSV, Y Combinator, Stanford University
- Founders
- Dr. Jane Doe, Dr. John Smith
- Company Description
- mFluiDx is a healthcare diagnostics company specializing in developing rapid, low-cost, and easy-to-use diagnostic tests for infectious diseases. Their innovative technology enables point-of-care testing, providing quick and accurate results to improve patient outcomes. mFluiDx's focus on addressing the global need for accessible and timely diagnostics positions them as a key player in the healthcare industry.
- Market
- Health Diagnostics
- Location
- Pleasanton, CA, US
- Coinvestors
- SOSV, Y Combinator